- Visibility 15 Views
- Downloads 3 Downloads
- DOI 10.18231/j.ijmmtd.2022.008
-
CrossMark
- Citation
Evaluation of microbial infections of ear and their susceptibility pattern in a tertiary care hospital
- Author Details:
-
Anisha Sunil
-
P Kennedy Kumar *
-
Somu L
-
K S Sridharan
Background
Ear infections are common worldwide. Nearly 0.065 to 0.33 billion people suffer from ear infections leading to loss of hearing in about 60% of them.[1] Because of its close proximity of the middle ear to the brain, infections of them if not treated appropriately and promptly can lead to intracranial infections and complications with high morbidity and mortality. [2] The majority of these infections are bacterial in origin with increasing pyogenicity.[3] The imperceptive, inaccurate, inappropriate use of antibiotics has caused the advent of multiple resistant strains of bacteria which is now a worldwide public health threat.[4], [5] Some factors such as low socio-economic status, lack of hygiene, insufficient health care, overcrowding and recurrent upper respiratory tract infections plays a major role for ear infections in low and middle-income countries. [6], [7] Hence, the importance of knowledge of the local pattern of infective organisms, their susceptibility pattern and their extent of antibiotic resistance is essential in the developing countries for proper management of patients with ear infections.[8] However, antibiotic resistance is a concerning global issue listed among the major threats to public health by the World Health Organization. [9]
Keeping in view the widespread use of antibiotics in the community and the high rate of antibiotic resistance, this study was undertaken to unravel the void left in otological microbiome.
Aims and Objectives
To study the microbiological profile of ear infections
To study the antibiotic susceptibility pattern of the bacterial isolates.
Materials and Methods
A retrospective analysis of culture and antibiotic susceptibility reports of ear samples representing middle ear infections sent from the Otorhinolaryngology department during the period 1st June to 30th September 2019 were retrieved using HIS (Hospital information software) at a tertiary care center in South India.
Isolation and identification of bacteria
The samples that were received at the Clinical Microbiology laboratory were subjected to Gram stain and then processed for the isolation of pathogens by inoculating into Blood agar, Chocolate agar and Mac-Conkey agar. The culture plates were incubated at 37°C and observed for the presence of growth at the end of 24 and 48hrs. Plates showing no growth at the end of 48 hours were reported as NO Growth. Those plates which showed growth were further processed for the identification of pathogens conventionally using appropriate biochemical reactions. Antibiotic susceptibility testing of the isolates were performed as per CLSI guidelines (2016 guidelines). The culture plates which grew mould and yeast were further subcultured into Sabouraud’s Dextrose Agar and identified at species level using appropriate techniques.
The test results archived from the HIS were tabulated to look for the microbiological profile and the susceptibility pattern of the pathogens.
Results
A total of 325 middle ear samples were analyzed during the study period out of which 23 of them showed no growth. Amongst the 302 samples, 325 pathogens were isolated in which 23 of them grew 2 pathogens. Out of the 325 pathogens that were analyzed, it was almost equally distributed between both genders. 50.63 % in men and 49.38% in women. (n=325) The predominant age group affected was the 30-45 years which was about 32.3% (n-325). The majority of the isolates were Gram negative bacilli 57 % (n-186), followed by Gram positive cocci 38 % (n- 122) and the remaining 5 % were fungi (n-17). ([Figure 1]) shows the breakdown of organisms isolated from various specimens in this study.
The Antibiotic susceptibility pattern of Gram-negative bacilli in this study is shown in ([Table 1]). Multidrug resistance among GNB were seen in 17 isolates (9.1%), with the most common organism being Pseudomonas aeruginosa 12(6.4%), followed by Klebsiella pneumoniae 2 (1.07%), Proteus spp, 2(1.07%), Acinetobacter spp 1(0.5%).
The Antibiotic susceptibility pattern of Gram-positive cocci in this study is shown in ([Table 2]). Methicillin resistance among Staphylococcal isolates was 22.6%(n=122) of which 10 were Staph aureus (11.12%; n=90) and the rest 16 were CONS (64%; n=25). Overall susceptibility percentage of the antibiotics towards the clinical isolates is shown in ([Table 3]).

Antibiotics |
Escherichia (n=6)% |
Klebsiella pneumoniae (n=15)% |
Acinetobacter (pp (n=4)% |
Enterobacter spp (n=4)% |
Proteus spp (n=15)% |
Morganella spp (n=2)% |
Providencia spp (n=1)% |
Citrobacter spp(n=3) % |
Pseudomonas spp (n=136)% |
Ampicillin |
3 (50%) |
Not reported |
Not reported |
||||||
Cephalexin |
3 (50%) |
6 (40%) |
|||||||
Cefotaxime |
4 (66.6%) |
11 (73.3%) |
3 (75%) |
4 (100%) |
11 (73.3%) |
2 (100%) |
1 (100%) |
2 (66.6%) |
Not reported |
Cefatazidime |
4 (66.6%) |
11 (73.3%) |
3 (75%) |
4 (100%) |
11 (73.3%) |
2 (100%) |
1 (100%) |
2 (66.6%) |
111 (81.6%) |
Cefaperazone sulbactum |
6 (100%) |
15 (100%) |
3 (75%) |
4 (100%) |
15 (100%) |
2 (100%) |
1 (100%) |
3 (100%) |
125 (91.9%) |
Piperacillin tazobactum |
6 (100%) |
15 (100%) |
3 (75%) |
4 (100%) |
15 (100%) |
2 (100%) |
1 (100%) |
3 (100%) |
125 (91.9%) |
Ciprofloxacin |
2 (33.3%) |
11 (73.3%) |
3 (75%) |
4 (100%) |
13 (86.6%) |
1 (50%) |
1 (100%) |
2 (66.6%) |
104 (76.4%) |
Levofloxacin |
4 (66.6%) |
13 (86.6%) |
4 (100%) |
4 (100%) |
14 (93.3%) |
1 (50%) |
1 (100%) |
3 (100%) |
112 (82.3%) |
Amikacin |
6 (100%) |
15 (100%) |
4 (100%) |
4 (100%) |
13 (86.6%) |
2 (100%) |
1 (100%) |
3 (100%) |
114 (83.8%) |
Tobramycin |
6 (100%) |
15 (100%) |
4 (100%) |
4 (100%) |
13 (86.6%) |
2 (100%) |
1 (100%) |
3 (100%) |
115 (84.5%) |
Cefipime |
6 (100%) |
13 (86.6%) |
3 (75%) |
4 (100%) |
14 (93.3%) |
2 (100%) |
1 (100%) |
3 (100%) |
125 (91.9%) |
Imipenam |
6 (100%) |
15 (100%) |
3 (75%) |
4 (100%) |
15 (100%) |
2 (100%) |
1 (100%) |
3 (100%) |
136 (100%) |
Meropenam |
6 (100%) |
15 (100%) |
3 (75%) |
4 (100%) |
15 (100%) |
2 (100%) |
1 (100%) |
3 (100%) |
136 (100%) |
Polymyxin B |
6 (100%) |
15 (100%) |
4 (100%) |
4 (100%) |
Not reported |
3 (100%) |
136 (100%) |
Antibiotics |
Staphylococcus aureus (n=90)% |
Coagulase Negative Staphylococcus (n=25)% |
Streptococcus spp(n=7)% |
Ampicillin |
50 (55.5%) |
9 (36%) |
5 (71.4%) |
Cephalexin |
82(91.1%) |
18 (72%) |
5 (71.4%) |
Cefotaxime |
80 (88.8%) |
19 (76%) |
5 (71.4%) |
Gentamycin |
74 (82.2%) |
22 (88%) |
Not reported |
Ciprofloxacin |
53 (58.8%) |
12 (48%) |
7 (100%) |
Erythromycin |
53 (58.8%) |
9 (36%) |
7 (100%) |
Clindamycin |
79 (87.7%) |
20 (80%) |
7 (100%) |
Vancomycin |
90 (100%) |
25(100%) |
6 (85.7%) |
Linezolid |
90 (100%) |
25 (100%) |
6 (85.7%) |
Drugs |
GPC% |
GNB% |
Combined% |
Ampicillin |
52.45% (n=122) |
50% (n=6) |
52.34%(n=128) |
Cephalexin |
86.06%(n=122) |
42.85%(n=21) |
79.72%(n=143) |
Cefotaxim |
85.24%(n=122) |
78%(n=50) |
83.13%(n=172) |
Ceftazidime |
Not reported |
81.18%(n=186) |
81.18%(n=186) |
Cefaperazone sulbactum |
93.54%(n=186) |
93.54%(n=186) |
|
Piperacillin tazobactum |
93.54%(n=186) |
93.54%(n=186) |
|
Cefipime |
91.93%(n=186) |
91.93%(n=186) |
|
Amikacin |
87.09%(n=186) |
87.09%(n=186) |
|
Tobaramycin |
87.63%(n=186) |
87.63%(n=186) |
|
Imipenem |
99.46%(n=186) |
99.46%(n=186) |
|
Meropenem |
99.46%(n=186) |
99.46%(n=186) |
|
Polymyxin B |
100%(n=186) |
100%(n=186) |
|
Vancomycin |
100%(n=122) |
Not reported |
100%(n=122) |
Linezolid |
100%(n=122) |
100%(n=122) |
|
Gentamycin |
83.47%(n=115) |
83.47%(n=115) |
|
Erythromycin |
56.55%(n=122) |
56.55%(n=122) |
|
Clindamycin |
86.08%(n=115) |
86.08%(n=115) |
Organisms |
1st Line |
2nd Line |
Topical |
Remarks if any |
Gram positive organisms |
||||
Staphylococcus aureus & CONS |
1st Preferences Amoxicillin/ Ampicillin+ cloxacillin Cephalexin Erythromycin Ciprofloxacin 2nd Preferences Amoxy-clauvulinic acid |
1st Preferences Cefotaxime Gentamycin 2nd Preferences Vancomycin Linezolid Clindamycin |
Ciprofloxacin Ofloxacin Gentamycin Mupirocin |
If allergic to penicillin group other group of antibiotics like macrolides or Quinolones to be considered for the treatment |
Streptococcus spp |
1st Preferences Ampicillin Cephalexin Erythromycin Ciprofloxacin Azithromycin |
1st Preferences Cefotaxime 2nd Preferences Vancomycin Linezolid |
Ciprofloxacin Mupirocin |
If allergic to penicillin group other group of antibiotics macrolides or Quinolones to be considered for the treatment |
Gram Negative organism |
||||
Pseudomonas spp Klebsiella pneumoniae Proteus spp Acinetobacter spp Escherichia coli Enterobacter spp Morganella spp Providencia spp |
Amoxy-clauvulinic acid (not for Non-fermenters) Ciprofloxacin/ Ofloxacin |
1st Preferences Cefotaxime Ceftazidime Cefaperazone- sulbactum Piperacillin- tazobactum Amikacin 2nd Preferences Levofloxacin Cefipime Imipenam Meropenam Polymyxin B |
Amikacin Tobaramycin Ciprofloxacin Oflaxacin |
-Pseudomonas spp intrinsically resistant to Cefotaxime, - Proteus spp, Morganella spp & Providencia spp are intrinsically resistant to Polymyxin B |
Discussion
In this study the prevalence of bacteria was 94.76 %. Gram-negative bacteria (GNB) were predominantly isolated from the discharging ears (57%) compared to Gram- positive bacteria (38%). This study revealed that gender does not have an influence on the chances of getting an infected middle ear. Similarly, most studies have reported that there isn’t any clear gender-based differences in the risk of acquiring ear infections.[10], [11] The infections of the ear are common among all age groups[12] so identifying the microbial etiology and antibiotic susceptibility appropriately will help in the management and prevention of antibiotic resistance. In our study the most common age group affected was 30-60 years of age which corresponds with other Indian studies as well. [13] Whereas in some studies it shows a predilection to young children and adolescents. [14], [15]
The most commonly isolated pathogen in our study was Pseudomonas aeruginosa. It is highly virulent; even though it may be regarded as an opportunistic pathogen, it can infect immunocompetent persons affecting any type of tissue. [16] Our finding is consistent with studies done in Riyadh,[17] UAE,[18] Pakistan[19] and Saudi Arabia. [20] Following Pseudomonas aeruginosa, the second most common organism isolated was Staphylococcus aureus. It is observed that both Gram-positive and Gram-negative organisms are responsible for middle ear infections. The results of this present work showed that P. aeruginosa was the most commonly isolated pathogen (41.8%) followed by S. aureus, Klebsiella pneumoniae, Proteus spp., respectively. Similar findings have been observed in Ireland,[21] Pakistan, [22] Greece[23] and other parts of the world which reported that P. aeruginosa and S. aureus are the most common organisms isolated from the cases of otitis media.
This study also showed that 17 swabs (5%) showed the presence of fungus (yeast/mould). The probable reasons for fungal ear infection include perennial warm, humid temperature and environmental pollution.[24], [25], [26] The magnitude of fungal infections is lesser when compared to bacterial ear infections. There is a similar pattern of organisms isolated in the tropical countries such as Africa, Singapore, Nigeria, and Pakistan when compared to the studies in India. There would be variations in the microbial profile of the organisms isolated in different parts of the world. Still, Pseudomonas and Staphylococci cause the majority (65.91%) of middle ear infections in tropical countries. [27]
Pseudomonas aeruginosa showed 76.4% sensitivity with ciprofloxacin, 81.6% with ceftazidime, 83.8% with amikacin, 91.9% sensitivity with piperacillin/tazobactam, and 100% sensitivity with Imipenem, Meropenem, Colistin, and Polymyxin B in our study. MDR strains accounted to 9.1% and is slowly on the rise. The higher rate of multidrug resistance may be due to the miss use of antibiotics. [28] These results were found to be in concordance with other Indian and world studies as well. [29], [30], [31], [32], [33], [34], [14], [15], [28]
Staphylococcus species were susceptible with ampicillin in 55.5% cases in our study. In study by Aslam et al[33] resistance with ampicillin and amoxycillin was found to be 77.2%. Sensitivity with ciprofloxacin was 58.8% in our study. In some other studies[29], [30], [34] the Staphylococcus species sensitivity with ciprofloxacin was higher (83.0%-95.0%). Vancomycin, linezolid, and teicoplanin were 100% sensitive and also against MRSA (22.6%), thus making these agents as the drug of choice for same. [32] No pan-drug resistant isolates were encountered in our study and a total of 43 isolates have shown multi drug resistance in our study (13.2%) which is significant in number.
Hence it is imperative to do a culture and sensitivity pattern of ear infections for effective management; thereby reducing further complications and improving clinical outcomes.
Based upon our study, the following guidelines are used for the efficacious management of ear infections is shown in ([Table 4]).
Conclusion
In accordance with many other studies, this study displays that there can be differences in the organisms affecting the middle ear and their susceptibility patterns. Pseudomonas aeruginosa and Staphylococcus spp., were found to be the most common organisms in our study. Pseudomonas aeruginosa was showing resistance against commonly used antimicrobials like Fluoroquinolones, cephalosporins and reduced sensitivity to aminoglycosides and macrolides. Staphylococcus species were highly resistant to ampicillin and beta-lactam antibiotics and ciprofloxacin. Therefore, evaluation of microbiological pattern and highlighting the need for routine culture and antimicrobial susceptibility testing in local area becomes useful in prescribing empirical antibiotics for efficacious treatment of otitis media, thereby minimalizing its complications and emergence of resistant strains. [32]
Conflicts of Interest
The authors declare no potential conflict of interest with respect to research, authorship, and/or publication of this article.
Source of Funding
None.
References
- K K Shrestha, A Barakoti, A S Rijal, A Dhungana. Bacteriological profile and antimicrobial sensitivity of common ear infections. Nepal Med Coll J 2018. [Google Scholar]
- E D Kitcher, A Jangu, K Baidoo. Emergency ear, nose and throat admissions at the Korle-Bu Teaching Hospital. Ghana Med J 2007. [Google Scholar]
- V K Poorey, A Iyer. Study of bacterial flora in CSOM and its clinical significance. Indian J Otolaryngol Head Neck Surg 2002. [Google Scholar] [Crossref]
- A Ali, S B Naqvi, D Sheikh. Resistance pattern of clinical isolates from cases of chronic ear infection II. Pak J Pharma Sci 1998. [Google Scholar]
- B Spellberg, R Guidos, D Gilbert, J Bradley, H W Boucher, W M Scheld. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008. [Google Scholar]
- H Kumar, S Seth. Bacterial and fungal study of 100 cases of chronic suppurative otitis media. J Clin Diagn Res 2011. [Google Scholar]
- O V Akinpelu, Y B Amusa, E O Komolafe, A A Adeolu, A O Oladele, S A Ameye. Challenges in management of chronic suppurative otitis media in a developing country. J Laryngol Otol 2008. [Google Scholar]
- B Edwin, V Prasanna, I Kannan, V H Katiyar, E Dhanapal. Incidence of bacterial colonization in the oropharynx of patients with ear, nose and throat infections. Int J Med Sci Public Health 2014. [Google Scholar]
- . World Health Organization, Antimicrobial Resistance: Global Report on Surveillance, World Health Organization. 2014. [Google Scholar]
- V Yiengprugsawan, A Hogan. Ear infection and its associated risk factors, comorbidity, and health service use in Australian children. Int J Pediatr 2013. [Google Scholar] [Crossref]
- J L Paradise, H E Rockette, D K Colborn. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997. [Google Scholar]
- C D Bluestone, J O Klein. Otitis Media in Infants and Children. 4th Edn.. 2007. [Google Scholar]
- T U Samanth, S G Jha, V Sinha, S Dadhich. Bacteriology and drug susceptibility in chronic suppurative otitis media in Ear, Nose, and Throat outpatient and inpatient department of tertiary care Hospital, Bhavnagar. Indian J Otol 2017. [Google Scholar] [Crossref]
- R Shyamala, P S Reddy. The study of becteriologigal agents of chronic suppurative otitis media: Aerobic culture and evaluation. J Microbiol biotech Res 2012. [Google Scholar]
- J Gulati, P L Tondon, W Singh, A S Bias. Study of Bacterial Flora in Chronic suppurative otitis media. Indian J Otolaryngol Head Neck Surg 1969. [Google Scholar]
- J B Lyczak, C L Cannon, G B Pier. Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microbes Infect 2000. [Google Scholar] [Crossref]
- M S Attallah. Microbiology of chronic suppurative otitis media with cholesteatoma. Saudi Med J 2000. [Google Scholar]
- S Yeli, H A Fattah. Bacterial isolates and their antibiotic susceptibility in chronic discharging ears in population. Int J Curr Microbiol Appl Sci 2014. [Google Scholar]
- A Sattar, A Alamgir, Z Hussain, S Sarfraz, J Nasir, Badar-E-Alam. Bacterial spectrum and their sensitivity pattern in patients of chronic suppurative otitis media. J Coll Physicians Surg Pak 2012. [Google Scholar]
- F Addas, M Algethami, N Mahmalji, S Zakai, T Alkhatib. Bacterial etiology and antimicrobial sensitivity patterns of ear infections at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. J Nat Sci Med 2019. [Google Scholar] [Crossref]
- K Mukassabi. Bacteriology of discharging ears. Ir Med J 2007. [Google Scholar]
- N U Khan, N Ali, N M Afridi, M Arshad. Sensitivity and spectrum of bacterial isolates in infectious otitis externa. J Coll Physicians Surg Pak 2004. [Google Scholar]
- J Bardanis, D Batzakakis. Types and causes of otorrhea. Auris Nasus Larynx 2003. [Google Scholar]
- L García-Agudo, P Aznar-Marín, F Galán-Sánchez, P García-Martos, P Marín-Casanova, M Rodríguez-Iglesias. Otomycosis due to filamentous fungi. Mycopathologia 2011. [Google Scholar] [Crossref]
- K R Aneja, C Sharma, R Joshi. Fungal infection of the ear: A common problem in the North Eastern part of Haryana. Int J Pediatr Otorhinolaryngol 2010. [Google Scholar] [Crossref]
- A Yassin, A Maher, M K Moawad. Otomycosis: A survey in the Eastern Province of Saudi Arabia. J Laryngol Otol 1978. [Google Scholar] [Crossref]
- P M Mane, A Basawraju. Clinical significance of microbial flora in middle ear infections and its implications. Trop J Med Res 2016. [Google Scholar]
- A Sharma, N Pyadala. Bacterial etiology of otitis media and their antibiogram among patients attending tertiary care hospital. Int J Otorhinolaryngol Head Neck Surg 2020. [Google Scholar] [Crossref]
- M Tahir, A Jawaid, A Abdullah, M A Najam. Bacterial culture and sensitivity in active chronic otitis media: 500 cases in combined military hospital Rawalpindi. Pak J Otolaryngol 2012. [Google Scholar]
- J Madana, D Yolmo, R Kalaiarasi, S Gopalakrishnan, S Sujata. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children. Int J Pediatr Otorhinolaryngol 2011. [Google Scholar] [Crossref]
- I A Mirza, L Ali, M Arshad. Microbiology of chronic suppurative otitis media-experience at Bahawalpur. Pak Armed Forces Med. Pak Armed Forces Med J 2008. [Google Scholar]
- A Agrawal, D Kumar, A Goyal, S Goyal, N Singh, G Khandelwal. Microbiological profile and their antimicrobial sensitivity pattern in patients of otitis media with ear discharge. Indian J Otol 2013. [Google Scholar] [Crossref]
- N A Aslam, Z Ahmad, R Azim. Microbiology and drug sensitivity pattern of chronic suppurative otitis media. J Coll Physicians Surg Pak 2004. [Google Scholar]
- K M Nia, G Sepehri, H Khatmi, M R Shakibaie. Isolation and antimicrobial susceptibility of bacteria from chronic suppurative otitis media patients in kerman, iran. Iran Red Crescent Med J 2011. [Google Scholar]